[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-AZTR":3,"homepage-market-summary":31,"stock-news-AZTR":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"AZTR","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Azitra Inc","NYSE American",null,"PHARMACEUTICAL PREPARATIONS","Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.","13","Branford, CT",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},0.132,0.1337,0.1383,0.1297,0.1285,0.0035,2.72,805090.015822,815,0.1329,1.09,0.1,7024101.042834243,3.2,827,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},9,[176,182,188,194,200,205,211,216,221],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"A 3% fee on gross proceeds applies if Azitra (AZTR) sells stock under its new agreement. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxNSWVrcW1yTW54MkJVcmloejlTbXEwMGRlUGFoOHB5MWloUGMwLVNHbEdfMTRzVjBzZDBSUm9zbVdFN3BiT3dtdm5GUGJ2djBxb3hhZm9KY0JDVkRPazR2Tks2S3pBbkJZODNrU1hNMW9FSDlNRWxKWGhoa3FEM0I5eHdaMDBTazBjcE5BYXladExuZV9pZ1hTemhuaXhXNDd4?oc=5","Mon, 28 Sep 2026 20:50:52 GMT","A 3% fee on gross proceeds applies if Azitra (AZTR) sells stock under its new agreement. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Azitra Launches At-the-Market Equity Offering Program - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxQZHBEZjNHdGFlU3N3dXY0WlZtZmFaSjJFekh4QlZjYjZkQ19nR29PR2VPRy1xRnZtYm5SQzZoZWYzYm5LV0w3MmxlMjdCUnlzRHNwNWsxZWFRNXVMbE5jRW8zWUtnb1Z6VUxqNldXdzNmWWhiX0cwS3lTWDRxVGUwaDlFUHJIenpxZ1JNbjRqOEtSSGg1SkVzZzkyR1M1N2MwVjVuckRJSTM2VUFGWFlRQXhwMU1tYWdreXJEblhUTEdWcGpsUnh0THg0anNSV1NaT3p5aTktVQ?oc=5","Tue, 29 Sep 2026 21:28:00 GMT","Azitra Launches At-the-Market Equity Offering Program The Globe and Mail","The Globe and Mail",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPMnlQSy1qU1c3OEhMbFh6YVVoclVFaENtVGZYZERkV0xTT3lMYXFiRzBQX2F6ZUYtdGdWNnVxQ3N6QnpHMTVpV2hhOHppd1p3WUJFeXpyYjY0eEo1N1VtRGFVTXpEamxfTWJFbEU4eTNxWGtFOTdXRjFMbkNDMHdLVlkyRWczdlRMakVjVG9ralVYbDRwczRqMXdMZzdySmNoWHl2andVYzR0aXhKZFlZUExHQ3JvZjY0ZmVTRA?oc=5","Tue, 29 Sep 2026 21:06:03 GMT","12 Health Care Stocks Moving In Tuesday's After-Market Session Benzinga","Benzinga",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Azitra Launches $3.5 Million ATM Equity Program With A.G.P.\u002FAlliance Global Partners - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxPdkFKQ1ZURWlRWk9Lcl9wZnF0XzZPUjlSM1kxQ0NHTmtFaTZqT0Jzbi1LbXhlTlI2MjM3SnJGWVZ2VHZ2Nm01ckJmaWtfNkp1WlF5eTN5d0lvd3dUbUh1SmxWaExZTk02VHBIaGR3OFBWc0JGb3AtM2RIdE10VnZXSnY3YVlnWnBGNWk3dWJlcVZNLU92QThCUURzNFIyTTV3d050WlByWU03RFdmTnBOMXBmWDYxWVM3Wk91dnRVVVN1QWphcktkcnZhOS1MOWFWYWlDNlVmMFZkNWMz?oc=5","Mon, 28 Sep 2026 20:53:09 GMT","Azitra Launches $3.5 Million ATM Equity Program With A.G.P.\u002FAlliance Global Partners TradingView","TradingView",{"title":201,"link":202,"pubDate":203,"description":204,"source":181},"Some targeted cancer drugs cause painful rashes in about 50%–80% of patients. Azitra can now enroll a second group. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxOeEluV2hiVFJkWE5ZZjJud2lSUG0zYjdDRWhaVy1FUzhDZnpBZ0ljRUw0cjdCWlJmdjlkcldPU25PUVFUVDVzTnMtZExSdlZlTEVqaDVyYlNYVUFscC0tSGljNF83MzhMam5RNWpkbmsweDBGTEVtSzZPekpWeUdUb2gxeEUyY21IX2pzMHVVN3hBRHpWbzlDeEVwdzY2TV9pUTBndEpDYWZYbGxGTXZfVTZEUVhRTUxCd1E?oc=5","Thu, 01 Oct 2026 12:00:00 GMT","Some targeted cancer drugs cause painful rashes in about 50%–80% of patients. Azitra can now enroll a second group. Stock Titan",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"(AMEX: AZTR) Share Price, AZTR Stock News, AZTR Share Price & Updates - kalkine.ca","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiTkFVX3lxTE1sYVJnbkFZMGRrV3V4S0RvMG5LdW5DaUpxX0ZVUUM2Zm5zdXJLRXMwRDdCeVlPcjdsUWR5ZHhHRmQ4ZnJDdHh3NzBQTGR4Zw?oc=5","Mon, 28 Sep 2026 23:07:00 GMT","(AMEX: AZTR) Share Price, AZTR Stock News, AZTR Share Price & Updates kalkine.ca","kalkine.ca",{"title":212,"link":213,"pubDate":214,"description":215,"source":193},"12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQbWx5Mmg4Q2NZRlA2NDFVX3R1b2pqT1l1THd5cC1lVEV5Z3l6ZnBJZnNNNGZ6Z09XQ2kzWTBDVWVSYmEtSTVVQmViclEzSXlhSFpLalg4OGZLN2FIbG1MaFlSOFdvaWtuY19MbXhacTNQQVg0WDJaNkdyMHZGUm1rRnVVUWFVODQxNkRlNlpsMldBbHZ6dnloOHF6YmVndmo3V0dlMFdoNGVUSDZwSnpWS0pXYTFfU2NaUHg4WnN3?oc=5","Thu, 01 Oct 2026 21:06:11 GMT","12 Health Care Stocks Moving In Thursday's After-Market Session Benzinga",{"title":217,"link":218,"pubDate":219,"description":220,"source":193},"12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxONGJVYlRUSzl6SUh0V3JHZ09NV05ZeXpmWmdmV3M3M0hIMzM0dmM1RTV6ZGFBUHVGWnI2MmlSSk5NbFJLYWJKVzZ5WUhKd29fZzlkY2gtSXVOcDBYVUZvWmdlbDE1dlZiVm13TjlKVmk3cGYxZHUycDdKY1pmWDhBYmdKVUlrQUp2bk9yYkRCcTZiWGNLdDM0YnFvcmpJeTZuaTNlc2FKSzNucmwzVXNHWXZsQzRQSUk?oc=5","Tue, 29 Sep 2026 17:06:01 GMT","12 Health Care Stocks Moving In Tuesday's Intraday Session Benzinga",{"title":222,"link":223,"pubDate":224,"description":225,"source":226},"Azitra Advances ATR04-484 Trial to Second Cohort - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxQZnMwV2cxNm5YVVU0dThZOU9Ca3EzNU5ZLWs1UmY2ME9icFY3RWNCQ2w5dlZTVFhsMU85MG1DYlA5SmVFVE1KZ1VueXBPOGp2WUptWl9BeGpMMWtLbXRESDdUTlRYc0dTNjJHVUN3VV9Bb1pYcjFsM3duRlNkdTZVUUpBZVV1U3ljSTJjUmdySnNBd2pYZVhXWkRZaEh6OWh1WFE?oc=5","Thu, 01 Oct 2026 12:39:16 GMT","Azitra Advances ATR04-484 Trial to Second Cohort TipRanks","TipRanks"]